Evaluation of Myocardial Contractility Determination with Tissue Tracking Echocardiography after Levosimendan Infusion in Patients with Poor Left Ventricular Function and Hemodynamics
DOI:
https://doi.org/10.1532/HSF98.2014415Abstract
Background: The aim of this study was to assess the effect of conventional inotropic drugs compared to levosimendan using tissue tracking echocardiography in the early postoperative period for patients with low ejection fraction undergoing coronary artery bypass graft (CABG) surgery.
Methods: We prospectively analyzed 115 patients (69 male, 46 female) who planned for elective coronary artery bypass surgery with low ejection fraction, ?% 30, from September 2012 to December 2013. Patients were divided into two groups. Levosimendan was used at a loading dose of 15 ?g/kg/min for the first twenty minutes, and continued at a maintenance dose of 0.2 ?g/kg/min six hours before the anesthetic induction in group I (n = 47, 23 male, mean age 67.16 ± 4.72 years). Dopamine at 10 ?g/kg/min and/or dobutamine at 10 ?g/kg/min were used at the time of weaning from cardiopulmonary bypass in group II (n = 68, 47 male, mean age 65.43 ± 6.12 years). The patients were evaluated preoperatively and on the fifth postoperative day by transthoracic echocardiography. Patients were also evaluated just before the cardiopulmonary bypass and at the 12th and 24th hours on the first postoperative day by transesophageal echocardiography. Student t test and ?2 test were used for statistical analyses.
Results: There were no significant differences in demographics and preoperative hemodynamic parameters between groups I and II. Hemodynamic and echocardiographic parameters were significantly better in group I receiving levosimendan, compared to group II.
Conclusion: Levosimendan enhances functional myocardial tissue mass and ensures positive hemodynamic effect in the early postoperative period in patients with low ejection fraction undergoing elective CABG.
References
Aksun M, Karahan N, Adanir T, et al. 2009. Timing of levosimendan in cardiac surgery. Anatolian J Cardiol 9:223-30.nAlvarez J, Bouzada M, Fernandez AL, et al. 2006. Hemodynamic effects of levosimendan compared with dobutamine in patients with low cardiac output after cardiac surgery. Rev Esp Cardiol 59:338-45.nBorges AC, Kivelitz D, Walde T, et al. 2003. Apical tissue tracking echocardiography for characterization of regional left ventricular function: comparison with magnetic resonance imaging in patients after myocardial infarction. J Am Soc Echocardiogr 16:254-62.nD'hooge J, Heimdal A, Jamal F, et al. 2000. Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr 1:154-70.nDe Hert SG, Lorsomradee S, Cromheecke S, et al. 2007. The effects of levosimendan in cardiac surgery patients with poor left ventricular function. Anest Analg 104:766-73.nDe Luca L, Colucci WS, Nieminen MS, Massie BM, Gheorghiade M. 2006. Evidence-based use of levosimendan in different clinical settings. Review. Eur Heart J 27:1908-20.nFabiato A, Fabiato F. 1979. Calcium and cardiac excitation-contraction coupling. Ann Rev Physiol 41:473.nFiggitt DP, Gillies PS, Goa KL. 2001. Levosimendan. Drugs 61:613-27.nFollath F, Cleland JG, Just H, et al. 2002. Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial. Lancet 360:196.nGoebel B, Arnold R, Koletzki E, et al. 2007. Exercise tissue Doppler echocardiography with strain rate imaging in healthy young individuals: feasibility, normal values and reproducibility. Int J Cardiovasc Imaging 23:149-55.nGray R, Shah PK, Singh B, Conklin C, Matloff JM. 1981. Low cardiac output states after open heart surgery. Comparative hemodynamic effects of dobutamine, dopamine, and norepinephrine plus phentolamine. Chest 80:16-18.nLabriola C, Siro-Brigiani M, Carrata F, Santangelo E, Amantea B. 2004. Hemodynamic effects of levosimendan in patients with low output heart failure after cardiac surgery. Int J Clin Pharm Th 42:204-6.nLehmann A, Lang J, Boldt J, Isgro F, Kiessling AH. 2004. Levosimendan in patients with cardiogenic shock undergoing surgical revascularization: a case series. Med Sci Monit 10:89.nLiileberg J, Nieminen MS, Akkila J, et al. 1998. Effects of a new calcium sensitizer, levosimendan, on haemodynamics, coronary blood flow and myocardial substrate utilization early after coronary bypass grafting. Eur Heart J 19:660-3.nÖnem G, Saçar M, Aybek H, et al. 2012. Protective effects of cilostazol and levosimendan on lung injury induced by lower limb ischemia-reperfusion. Turkish J Thorac Cardiovasc Surg 20:577-83.nÖner S, Kür?at BA, Asuman S, Zuhal A, Ayd?n B. 1996. The comparison of the inotropic effects of levosimendan and amrinone after ischemia in isolated perfused guinea pig hearts. Turkish J Thorac Cardiovasc Surg 4:5-8.nPan C, Hoffmann R, Kühl H, Severin E, Franke A, Hanrath P. 2001. Tissue tracking allows rapid and accurate visual evaluation of left ventricular function. Eur J Echocardiogr 2:197-202.nRomson JL, Leung JM, Bellows WH. 1999. Effects of dobutamine on hemodynamics and left ventricular performance after cardiopulmonary bypass in cardiac surgical patients. Anesthesiology 91:1318-21.nSalomon NW, Plachetka JR, Copeland JG. 1981. Comparison of dopamine and dobutamine following coronary artery bypass grafting. Ann Thorac Surg 3:48-51.nSogaard P, Egeblad H, Pedersen AK, et al. 2002. Sequential versus simultaneous biventricular resynchronization for severe heart failure: evaluation by tissue Doppler imaging. Circulation 106:2078-84.nVoigt JU, Flachskampf FA. 2004. Strain and strain rate. New and clinically relevant echo parameters of regional myocardial function. Z Kardiol 93:249-58.nYa?ar S, Yava? S, Kervan Ü, Balc? M, Özgök A. 2012. The effect of high-dose GIK infusion on cytokin levels in beating heart coronary artery bypass graft surgery patients with left ventricular dysfunction. Turkish J of Thorac and Cardiovasc Surg 20:39-43.n
